Ryan Specialty Holdings Inc. (NYSE:RYAN) Given Average Rating of “Hold” by Analysts

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN) have earned a consensus rating of “Hold” from the nineteen analysts that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, six have given a hold recommendation, nine have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $47.8235.

Several research analysts recently weighed in on RYAN shares. Bank of America cut their target price on Ryan Specialty from $70.00 to $68.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $49.00 to $42.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Piper Sandler cut their target price on Ryan Specialty from $43.00 to $35.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Royal Bank Of Canada assumed coverage on Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 target price for the company. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $42.00 target price on shares of Ryan Specialty in a report on Friday, May 1st.

Ryan Specialty Trading Up 0.7%

Ryan Specialty stock opened at $31.51 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 2.90. The stock has a market cap of $8.33 billion, a PE ratio of 40.93, a P/E/G ratio of 0.74 and a beta of 0.68. The stock has a 50-day moving average price of $35.09 and a 200 day moving average price of $45.40. Ryan Specialty has a 52 week low of $29.28 and a 52 week high of $72.50.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.43 by $0.04. The company had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm’s revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.39 EPS. Equities research analysts predict that Ryan Specialty will post 2.05 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 26th. Shareholders of record on Tuesday, May 12th will be issued a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Tuesday, May 12th. Ryan Specialty’s dividend payout ratio is currently 67.53%.

Insiders Place Their Bets

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the firm’s stock in a transaction on Monday, February 23rd. The stock was purchased at an average price of $39.96 per share, for a total transaction of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. The trade was a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 52.03% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of institutional investors and hedge funds have recently bought and sold shares of RYAN. Royal Bank of Canada boosted its stake in shares of Ryan Specialty by 10.6% during the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock valued at $4,406,000 after buying an additional 5,739 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of Ryan Specialty by 25.1% in the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock valued at $367,000 after buying an additional 998 shares during the period. Goldman Sachs Group Inc. lifted its stake in Ryan Specialty by 46.3% in the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after buying an additional 119,055 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Ryan Specialty by 11.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock valued at $24,586,000 after buying an additional 33,667 shares during the last quarter. Finally, Creative Planning lifted its stake in Ryan Specialty by 15.4% in the second quarter. Creative Planning now owns 4,586 shares of the company’s stock valued at $312,000 after buying an additional 613 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.